A novel antibody discovery and screening platform needed to assess its market potential and develop a commercialization strategy.
Our client had developed a novel antibody technology capable of rapidly screening and selecting millions (and potentially billions) of antibody producing clones using a simple array technology, allowing the analysis of every single clone without the need for enrichment.
Our antibody consultants performed primary and secondary market analysis for the technology, engaging with future customers, end users and other stakeholders of the antibody industry. We profiled the emerging and existing competitor landscape for the proposed antibody technology application and investigated potential routes to exploitation.
We mapped out the markets and customers where the antibody technology would have the strongest potential, and identified key application areas, presenting the level of unmet need and the benefit the technology could add.
We interviewed the scientific teams of several antibody developers and gained further insight into competing antibody discovery and clone selection technologies. We gave robust, market-tested feedback to our client along with a low-risk commercialization roadmap.Back